Predict your next investment

Venture Capital
wrfcapital.com

See what CB Insights has to offer

Investments

139

Portfolio Exits

30

About WRF Capital

WRF Capital is the venture investment arm of Washington Research Foundation. An early-stage investor, that partner with entrepreneurs, local universities, research institutions and other investors to develop technology-based start-up companies. WRF Capital seeks to invest in innovations that occur in the life science, information technology and physical science sectors, as well as in opportunities where these sectors may converge. WRF specializes in investing at the earliest stages, and are often involved before a company has been formed.

WRF Capital Headquarter Location

2815 Eastlake Ave E Suite 300

Seattle, Washington, 98102,

United States

206-336-5600

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing WRF Capital

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find WRF Capital in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Research containing WRF Capital

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned WRF Capital in 1 CB Insights research brief, most recently on Apr 19, 2022.

Latest WRF Capital News

ThruWave Scores $6.4M Seed Financing

Sep 4, 2020

The funding round was led by E14 Fund and Ubiquity Ventures, and joined by Root Ventures, Blue Sky Capital, WRF Capital, and Tsingyuan Ventures. In-Q-Tel, Inc., a not-for-profit strategic investor for United States Government agencies, joined the round as an investor and customer. ThruWave was additionally awarded a $750,000 Phase II Small Business Innovation Research (SBIR) grant from the National Science Foundation to accelerate the development of its unique millimeter wave technology. ThruWave's high throughput X2 mmWave Imaging System provides unprecedented supply chain visibility by enabling warehouse and fulfillment center operators to see through packaging to the items inside. Unlike existing X-ray inspection systems, ThruWave's sensors use human-safe millimeter waves to enable safe operation alongside human workers in busy warehouses and fulfillment centers. ThruWave's analytics layer automatically interprets images to measure cube utilization, count items, and detect missing or damaged items, all at conveyor speed. ThruWave systems can automatically image and analyze up to 20,000 boxes per hour. "ThruWave makes the invisible visible," said ThruWave founder and CEO Matt Reynolds. "Our sensors do what existing cameras can't do - we see through cardboard boxes and plastic totes to look at the items inside. We also detect anomalies such as missing or damaged items. Our computer vision layer analyzes the images to extract critical process variables like item counts, or fill volumes. We enable our customers to dramatically improve accuracy and efficiency in their warehousing and order fulfillment operations." "ThruWave's groundbreaking millimeter wave technology addresses major pain points in both automated and manual material handling operations," said Calvin Chin, Managing Partner of E14 Fund. "Industry-wide, it is estimated that a typical e-commerce shipment is only 40% full, leading to tremendous waste in packaging material, shipping cost, and carbon footprint. ThruWave's unique sensors and software enable customers to regain control over their shipping cost and environmental impact." "ThruWave's high-throughput millimeter wave sensors have the potential to enhance national security by enabling the detection of items concealed by packaging," said Eileen Tanghal, Senior Partner at In-Q-Tel. "We are excited to partner with ThruWave to bring this `x-ray vision' capability to government customers who need high throughput, human-safe screening of mail, packages, and other items in an easily deployed form factor." About ThruWave Based in Seattle, Washington, ThruWave makes the Invisible Visible with human-safe, 3D millimeter wave imaging. ThruWave sensors and software analytics are an easy retrofit for existing conveyor and robotic material handling systems, enabling supply chain and logistics customers to measure and improve their inbound and outbound item handling. For more information, visit http://www.thruwave.com. About E14 Fund E14 Fund is the early stage venture capital firm for the MIT Media Lab community. E14 Fund invests in deep tech startups that are transforming traditional industries across a broad array of market-ready, scalable innovation such as sensors, AI/ML, robotics, health, synthetic biology and more. Officially affiliated with MIT, E14 Fund builds and supports a vibrant community of founders and companies with resources from across the MIT ecosystem. For more information, visit http://www.e14fund.com. About Ubiquity Ventures Ubiquity Ventures is a seed-stage institutional venture capital firm that invests in "software beyond the screen" startups. Ubiquity portfolio companies leverage smart hardware and machine intelligence to bring software into the real world, not just buried within computers and smartphones. See more details on the Ubiquity Ventures website at http://www.ubiquity.vc. About In-Q-Tel In-Q-Tel, Inc. is the nonprofit strategic investor serving as a trusted partner to government intelligence and national security agencies by sourcing, funding, and accelerating innovative technologies from the commercial startup community to strengthen the security of the U.S. and its allies. Learn more at http://www.iqt.org. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.

WRF Capital Investments

139 Investments

WRF Capital has made 139 investments. Their latest investment was in TransformativeMed as part of their Series A - II on May 5, 2022.

CBI Logo

WRF Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/6/2022

Series A - II

TransformativeMed

$1.2M

No

1

3/31/2022

Seed VC - II

Link Immunotherapeutics

$12M

No

2/8/2022

Seed VC

Wavely Diagnostics

$2.2M

Yes

6

1/19/2022

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

6/3/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/6/2022

3/31/2022

2/8/2022

1/19/2022

6/3/2021

Round

Series A - II

Seed VC - II

Seed VC

Seed VC

Series A

Company

TransformativeMed

Link Immunotherapeutics

Wavely Diagnostics

Subscribe to see more

Subscribe to see more

Amount

$1.2M

$12M

$2.2M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

6

10

10

WRF Capital Portfolio Exits

30 Portfolio Exits

WRF Capital has 30 portfolio exits. Their latest portfolio exit was AbSci on July 22, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/22/2021

IPO

$99M

Public

6

3/30/2021

Acquired

$99M

11

9/18/2020

IPO

$99M

Public

1

6/23/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

3/27/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/22/2021

3/30/2021

9/18/2020

6/23/2020

3/27/2019

Exit

IPO

Acquired

IPO

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Public

Subscribe to see more

Subscribe to see more

Sources

6

11

1

10

10

WRF Capital Team

5 Team Members

WRF Capital has 5 team members, including current Chief Executive Officer, President, Ronald Howell.

Name

Work History

Title

Status

Ronald Howell

Chief Executive Officer, President

Current

Jeff Eby

Chief Financial Officer

Current

Loretta L. Little

Washington Research Foundation

Managing Director

Current

John Reagh

Managing Director

Current

Thong Q. Le

Washington Research Foundation

Managing Director

Former

Name

Ronald Howell

Jeff Eby

Loretta L. Little

John Reagh

Thong Q. Le

Work History

Washington Research Foundation

Washington Research Foundation

Title

Chief Executive Officer, President

Chief Financial Officer

Managing Director

Managing Director

Managing Director

Status

Current

Current

Current

Current

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.